Prophylactic Mastectomy in BRCA1 and BRCA2 Mutation Carriers: Very Low Risk for Subsequent Breast Cancer

作者: Reinoutje Kaas , Senno Verhoef , Jelle Wesseling , Matti A. Rookus , Hester S. A. Oldenburg

DOI: 10.1097/SLA.0B013E3181C3C36D

关键词: Gene mutationMutation (genetic algorithm)MastectomyOncologyMedicineMammary glandCancerBreast cancerProphylactic MastectomyBreast diseaseInternal medicineSurgery

摘要: Aim:To examine the outcome of prophylactic mastectomy in a hospital-based series BRCA1/2 gene mutation carriers with and without history breast cancer.Patients Methods:A center-based consecutive 254 that had after normal

参考文章(28)
Timothy R Rebbeck, Tara Friebel, Henry T Lynch, Susan L Neuhausen, Laura Van’t Veer, Judy E Garber, Gareth R Evans, Steven A Narod, Claudine Isaacs, Ellen Matloff, Mary B Daly, Olufunmilayo I Olopade, Barbara L Weber, None, Bilateral Prophylactic Mastectomy Reduces Breast Cancer Risk in BRCA1 and BRCA2 Mutation Carriers: The PROSE Study Group Journal of Clinical Oncology. ,vol. 22, pp. 1055- 1062 ,(2004) , 10.1200/JCO.2004.04.188
Lisa J. Herrinton, William E. Barlow, Onchee Yu, Ann M. Geiger, Joann G. Elmore, Mary B. Barton, Emily L. Harris, Sharon Rolnick, Roy Pardee, Gail Husson, Ana Macedo, Suzanne W. Fletcher, Efficacy of Prophylactic Mastectomy in Women With Unilateral Breast Cancer: A Cancer Research Network Project Journal of Clinical Oncology. ,vol. 23, pp. 4275- 4286 ,(2005) , 10.1200/JCO.2005.10.080
Karen Lisa Smith, Muriel Adank, Noah Kauff, Kelly Lafaro, Jeff Boyd, Johanna B. Lee, Clifford Hudis, Kenneth Offit, Mark Robson, BRCA Mutations in Women with Ductal Carcinoma In situ Clinical Cancer Research. ,vol. 13, pp. 4306- 4310 ,(2007) , 10.1158/1078-0432.CCR-07-0146
DFAC Easton, D Thompson, L McGuffog, N Haites, A Schofield, RJ Scott, MC King, E Schubert, Y Bignon, M Stratton, D Ford, J Peto, R Eeles, B Ponder, S Gayther, J Chang-Claude, BHF Weber, U Hamann, J Benitez, A Osorio, H Eerola, H Nevanlinna, HT Lynch, S Narod, D Goldgar, G Lenoir, None, Cancer Risks in BRCA2 Mutation Carriers JNCI Journal of the National Cancer Institute. ,vol. 91, pp. 1310- 1316 ,(1999) , 10.1093/JNCI/91.15.1310
L C Verhoog, C T M Brekelmans, C Seynaeve, E J Meijers-Heijboer, J G M Klijn, Contralateral breast cancer risk is influenced by the age at onset in BRCA1-associated breast cancer British Journal of Cancer. ,vol. 83, pp. 384- 386 ,(2000) , 10.1054/BJOC.2000.1239
Shannon K. McDonnell, Daniel J. Schaid, Jeffrey L. Myers, Clive S. Grant, John H. Donohue, John E. Woods, Marlene H. Frost, Joanne L. Johnson, Diana L. Sitta, Jeffrey M. Slezak, Thomas B. Crotty, Robert B. Jenkins, Thomas A. Sellers, Lynn C. Hartmann, Efficacy of Contralateral Prophylactic Mastectomy in Women With a Personal and Family History of Breast Cancer Journal of Clinical Oncology. ,vol. 19, pp. 3938- 3943 ,(2001) , 10.1200/JCO.2001.19.19.3938
Noah D. Kauff, Edi Brogi, Lauren Scheuer, Dorothy R. Pathak, Patrick I. Borgen, Clifford A. Hudis, Kenneth Offit, Mark E. Robson, Epithelial lesions in prophylactic mastectomy specimens from women with BRCA mutations Cancer. ,vol. 97, pp. 1601- 1608 ,(2003) , 10.1002/CNCR.11225
Ford, D, Easton, DF, Bishop, DT, Narod, SA, Goldgar, DE and the Breast Cancer Linkage Consortium, None, Risks of cancer in BRCA1-mutation carriers The Lancet. ,vol. 343, pp. 692- 695 ,(1994) , 10.1016/S0140-6736(94)91578-4
Elisabeth L Dupont, M.Ann Kuhn, Christa McCann, Chris Salud, Janet L Spanton, Charles E Cox, The role of sentinel lymph node biopsy in women undergoing prophylactic mastectomy. American Journal of Surgery. ,vol. 180, pp. 274- 277 ,(2000) , 10.1016/S0002-9610(00)00458-X